Bernard Prudhon

De novo design of allosterically switchable protein assemblies

Mass photometry enables label-free tracking and mass measurement of single proteins on lipid bilayers

Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease

Diverse roles of the actin cytoskeleton in striated muscle

Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy

Metazoan MicroRNAs

Leishmania donovani Targets Dicer1 to Downregulate miR-122, Lower Serum Cholesterol, and Facilitate Murine Liver Infection

Differential Regulation of Lipoprotein and Hepatitis C Virus Secretion by Rab1b

Macrophage Cytokines: Involvement in Immunity and Infectious Diseases

Single-cell transcriptomic analysis of Alzheimer’s disease

Atg9 Vesicles Recruit Vesicle-tethering Proteins Trs85 and Ypt1 to the Autophagosome Formation Site

Lipid droplet breakdown requires Dynamin 2 for vesiculation of autolysosomal tubules in hepatocytes

Role of Rab GTPases in Membrane Traffic and Cell Physiology

Amyloid β peptide cleavage by kallikrein 7 attenuates fibril growth and rescues neurons from Aβ-mediated toxicity in vitro

Fiber Types in Mammalian Skeletal Muscles

Autophagy pathway: Cellular and molecular mechanisms

Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset

Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis

Dynamin 2 and human diseases

A Centronuclear Myopathy – Dynamin 2 Mutation Impairs Autophagy in Mice

A NEW CENTRONUCLEAR MYOPATHY PHENOTYPE DUE TO A NOVEL DYNAMIN 2 MUTATION

A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice